Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
Review
[키워드] Area
caused
clinical benefit
Covered
COVID-19
COVID-19 pandemic
cytokine
deficiency
disease
drug
effective drug
effector cells
epidemiological
epithelial cells
Evidence
expert
fatality
Google Scholar
Host
Hyperactivation
immune
immuno-modulation
immuno-pathology
imperative
incidence of COVID-19
innate immune system
Innate immunity
Interaction
interferon
Invasion
knowledge
Novel viruses
Pandemics
pathogenic mechanism
patients of COVID-19
Randomized controlled trial
repurposing
Research
SARS-CoV-2
Severe case
severity
Therapeutic benefit
Treatment
viral infection
Vitamin D
website
WHO
[DOI] 10.1080/14787210.2021.1905519 PMC 바로가기 [Article Type] Review
[DOI] 10.1080/14787210.2021.1905519 PMC 바로가기 [Article Type] Review